Baxter restructuring • Oak Street Health names provider wellness chief
Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.
Stay updated with breaking news from Billy Dunn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.
The FDA approved lecanemab, an Alzheimer’s drug developed by Eisai Co. Ltd. and Biogen Inc., under its Accelerated Approval pathway.
The US Food and Drug Administration granted accelerated approval Friday for the Alzheimer's disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of
The FDA’s decision comes after clinical trial results indicated that lecanemab slows cognitive decline somewhat in people with mild impairment from...
The Food and Drug Administration has approved the experimental Alzheimer’s drug Leqembi (lecanemab-irmb) for clinical use in patients with early disease.